Mhairi Copland, MB ChB

Experts Jorge Cortes and Mhairi Copland discuss recent updates in chronic myeloid leukemia (CML), including treatment strategies for refractory disease, novel agents, and clinical trial updates from the OPTIC and ASCEMBL trials. They highlight the use of new drugs and optimized doses, personalized approaches, and the potential of combining TKI therapy with immunological approaches for improved responses in CML patients.